<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7714572</article-id><article-id pub-id-type="doi">10.1155/2020/3160834</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Hydroethanolic Extract from <italic>Bridelia atroviridis</italic> M&#x000fc;ll. Arg. Bark Improves Haematological and Biochemical Parameters in Nicotinamide-/Streptozotocin-Induced Diabetic Rats</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6172-1192</contrib-id><name><surname>Noussi Djouwoug</surname><given-names>Clarice</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5382-9184</contrib-id><name><surname>Ngueguim</surname><given-names>Florence Tsofack</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kamkumo Gounoue</surname><given-names>Raceline</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Donfack Gouni</surname><given-names>Cl&#x000e9;mence</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4358-6593</contrib-id><name><surname>Kandeda</surname><given-names>Antoine Kavaye</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Philippe Djientcheu</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fifen</surname><given-names>Rodrigue</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5315-6285</contrib-id><name><surname>Djomeni Dzeufiet</surname><given-names>Desire Paul</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ngouela</surname><given-names>Silv&#x000e8;re</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0309-2655</contrib-id><name><surname>Sewald</surname><given-names>Norbert</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lenta</surname><given-names>Bruno Ndjakou</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8565-1181</contrib-id><name><surname>Dimo</surname><given-names>Theophile</given-names></name><email>dimo59@yahoo.com</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Animal Biology and Physiology, Faculty of Science, University of Yaound&#x000e9; I, P.O. Box 812, Yaound&#x000e9;, Cameroon</aff><aff id="I2">
<sup>2</sup>Department of Organic Chemistry, Faculty of Science, University of Yaound&#x000e9; I, P.O. Box 812, Yaound&#x000e9;, Cameroon</aff><aff id="I3">
<sup>3</sup>Department of Chemistry Organic and Biorganic Chemistry, University of Bielefeld, P.O. BOX 100131, D-33501, Bielefeld, Germany</aff><aff id="I4">
<sup>4</sup>Department of Chemistry, Higher Teacher Training College, University of Yaound&#x000e9; 1, P.O. Box 47, Yaound&#x000e9;, Cameroon</aff><author-notes><fn fn-type="other"><p>Academic Editor: Shagufta Perveen</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>25</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>11</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>2020</volume><elocation-id>3160834</elocation-id><history><date date-type="received"><day>16</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>23</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Clarice Noussi Djouwoug et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Bridelia atroviridis M&#x000fc;ll. Arg. (B. atroviridis</italic>) is a plant used in Cameroonian traditional medicine to manage diabetes. The effects of hydroethanolic barks extract from <italic>B. atroviridis</italic> were evaluated on diabetes disorders including hematology, inflammatory, and oxidative stress parameters. The in vitro antioxidant capacity of the hydroethanolic bark extract (70&#x02009;:&#x02009;30) was evaluated. Nicotinamide-/streptozotocin-induced diabetic rats were daily treated with the <italic>B. atroviridis</italic> extract for fifteen days. Glycemia were evaluated every 5 days, insulin sensibility test was performed, and haematological, inflammatory, and oxidative stress parameters were analysed. Histomorphometry of the pancreas was realized. The extract was able to scavenge free radicals in vitro and decrease significantly the blood glucose levels. The treatment resulted in a significant alleviation of insulin resistance, anemia, leukocytopenia, and thrombocytopenia observed in untreated diabetic rats. The extract significantly decreased proinflammatory cytokines TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and IL-10. The rate of reduced glutathione was increased in the pancreas, whereas the catalase activity and nitrite concentration were decreased. Diabetic control showed a reduced size of Langerhans islet, whereas the size of islets was large in treated groups. The hydroethanolic extract of <italic>B. atroviridis</italic> was able to improve glycemia and alleviate haematological and inflammatory parameters disorders observed in diabetic conditions, probably due to its antidiabetic, anti-inflammatory, and antioxidant capacities.</p></abstract><funding-group><award-group><funding-source>Deutscher Akademischer Austauschdienst</funding-source><award-id>57316173</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Diabetes is a metabolic disorder characterized by chronic hyperglycemia resulting from deficiency of secretion (type I diabetes) and/or insulin action (type II diabetes) [<xref rid="B1" ref-type="bibr">1</xref>]. In 2017, the International Diabetes Federation (IDF) estimated about 425 million adults with diabetes all over the world with 16 million in Africa, the number of diabetic patients is still growing worldwide, and more than 629 million could be suffering in 2045 [<xref rid="B2" ref-type="bibr">2</xref>]. This may be due to some disadvantages provided by the most available treatment, including drug resistance (reduction of efficiency), side effects, and even toxicity [<xref rid="B3" ref-type="bibr">3</xref>]. Morbidity and mortality could be due to the complications often occurred in this disease [<xref rid="B4" ref-type="bibr">4</xref>]. Microvascular changes are the main consequence of chronic hyperglycemia and lead to blindness, amputations, kidney disease, anemia, cardiovascular attack, brain complications, impairment in immunological response, and gastrointestinal system [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. In diabetic state, lipotoxicity and glucotoxicity generate oxidative stress and exacerbate inflammatory response [<xref rid="B7" ref-type="bibr">7</xref>].</p><p>Chronic hyperglycemia has a direct relationship with the development of an inflammatory condition marked by the increased expression of proinflammatory cytokines such as IL-1<italic>&#x003b2;</italic>, IL-6, TNF-<italic>&#x003b1;</italic>, and NF<italic>&#x003ba;</italic>B [<xref rid="B8" ref-type="bibr">8</xref>]. Evidence of these immunological changes involves variation in the levels of cytokines and chemokines, changes in the numbers and activation states of various leukocyte populations, apoptosis, and fibrosis. These disturbances are observed in the adipose tissue, liver, pancreatic islets, kidney, and vasculature [<xref rid="B7" ref-type="bibr">7</xref>].</p><p>The cumulative results of these transformations resulted from excess generation of reactive oxygen species (ROS) mediated by chronic hyperglycemia [<xref rid="B9" ref-type="bibr">9</xref>]. The development of complications related with diabetes takes place with ROS production, mainly O<sub>2</sub><sup>&#x02212;</sup> which induces cell dysfunction and oxidative lesion by protein denaturation pathway, lipid peroxidation, and damage to mitochondrial DNA [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>].</p><p>Recent studies showed that the majority of plasma antioxidants are depleted in diabetic state [<xref rid="B11" ref-type="bibr">11</xref>]. Therefore, future treatment of type 2 diabetes and its complications may include hypoglycemic, anti-inflammatory, and antioxidant drugs [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. Traditional medicine systems generally assume that synergy effects of all ingredients of the plants will bring about maximum therapeutic [<xref rid="B12" ref-type="bibr">12</xref>]. In Cameroon, particularly in the centre region (Mbalmayo), <italic>Bridelia atroviridis M&#x000fc;ll. Arg.</italic> (Euphorbiaceae) is used by local population to manage various ailments including diabetes, malaria, and venereal diseases. <italic>B. atroviridis</italic> methanolic leaves and stem bark extracts possess antifungal activity, and the decoction from its bark is used as purgative, diuretic, and aphrodisiac remedy [<xref rid="B13" ref-type="bibr">13</xref>]. Although ethnobotanical surveys of certain medicinal plants used in Cameroon do not indicate the traditional use of <italic>B. atroviridis</italic> on diabetes [<xref rid="B14" ref-type="bibr">14</xref>], some plants of the genus Bridelia have been cited as antidiabetic [<xref rid="B13" ref-type="bibr">13</xref>]. Meanwhile, the antidiabetic activity of <italic>Bridellia ferruginea</italic> [<xref rid="B15" ref-type="bibr">15</xref>], <italic>Bridelia micrantha</italic> [<xref rid="B16" ref-type="bibr">16</xref>], <italic>Bridelia ndellensis</italic> Beille [<xref rid="B17" ref-type="bibr">17</xref>], <italic>Bridellia grandis</italic> [<xref rid="B18" ref-type="bibr">18</xref>], and <italic>Bridellia retusa</italic> [<xref rid="B19" ref-type="bibr">19</xref>] has been proven. It was also reported that barks of all <italic>Bridellia</italic> Spp have similar medicinal uses in West Africa [<xref rid="B20" ref-type="bibr">20</xref>] motivating the investigation of the antidiabetic activity of <italic>Bridelia</italic> hydroethanolic extract. Hereby, we investigated the possible bioactivities of <italic>B. atroviridis</italic> hydroethanolic extract against some pathophysiological effects on nicotinamide-/streptozotocin-induced diabetes in rats.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Plant Material and Extract Preparation</title><p>
<italic>Bridelia atroviridis</italic> barks were harvested at Mbalmayo in December 2018. The plant was authenticated by Mr. Ngansop Eric, a botanist at the National Herbarium, Yaound&#x000e9; (Cameroon), in comparison with the specimen voucher N35241/HNC Cam. The barks were air-dried in the shade and pulverized into powder. A kilogram of powder from <italic>B. atroviridis</italic> was soaked in 5&#x02009;L of hydroethanolic solvent mixture (30% water and 70% ethanol; v/v) for 72 hours with regular agitation. Then, the mixture was filtered with Whatman paper No. 3, and the filtrate was evaporated to dryness using a rotatory evaporator (Buchi Rota vapor, Switzerland) at a temperature of 45&#x000b0;C. The residual water was removed by ventilation under a hood (Burdinola ST 1800) giving a powdered crude extract.</p></sec><sec id="sec2.2"><title>2.2. Phytochemical Analysis</title><p>The extract was screened for detection of different chemical families according to the standardized methods described by Odebiyi and Sofowora [<xref rid="B21" ref-type="bibr">21</xref>] and also by Gul et al. [<xref rid="B22" ref-type="bibr">22</xref>]. Briefly, phenolic compounds were detected using the ferrocyanide reaction; triterpenes and sterols were revealed by their reactivity with anhydrous acetate and sulphuric acid. Alkaloids were detected using Mayer's reagent, whereas the presence of saponins was revealed based on their foaming property. Tannins and flavonoids were revealed using ferric chloride and hydrochloric acid, respectively. Anthraquinones were detected in extract by the chloroform/petroleum system.</p></sec><sec id="sec2.3"><title>2.3. In Vitro Antioxidant Activities of <italic>B. atroviridis</italic></title><sec id="sec2.3.1"><title>2.3.1. DPPH Test</title><p>This test was performed as described by Aadil and collaborators [<xref rid="B23" ref-type="bibr">23</xref>]. The radical scavenging activities of the plant extract were evaluated spectrophotometrically using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical. When DPPH reacts with an antioxidant compound, which can donate hydrogen, it is reduced. The color change was measured at wave length, 517&#x02009;nm under UV/Visible light spectrophotometer. 50&#x02009;<italic>&#x003bc;</italic>L of the diluted extract (1000&#x02009;<italic>&#x003bc;</italic>g/mL in ethanol) were mixed with 150&#x02009;<italic>&#x003bc;</italic>L of 1,1-diphenyl-2-picrylhydrazyl (DPPH) ethanol solution and then diluted twofold serially resulting to a final extract concentrations range from 250 to 1.9531&#x02009;<italic>&#x003bc;</italic>g/mL. After 1 hour of incubation in the dark at room temperature, the optical densities were measured. Ascorbic acid (Vitamin C) was used as control. The radical scavenging activity fifty (RSA<sub>50</sub>, in %) was calculated [<xref rid="B23" ref-type="bibr">23</xref>].</p></sec><sec id="sec2.3.2"><title>2.3.2. ABTS Assay</title><p>The radical scavenging activities of crude extract were evaluated spectrophotometrically using the 2,2&#x02032;-azino-bis (3-ethylbenzothiazoline-6-sulphonic) acid (ABTS) free radical as described by Aadil and collaborators [<xref rid="B23" ref-type="bibr">23</xref>]. The extract (1000&#x02009;<italic>&#x003bc;</italic>g/mL) was three-fold serially diluted with ethanol. 50&#x02009;<italic>&#x003bc;</italic>L of the diluted extract was mixed with 150&#x02009;<italic>&#x003bc;</italic>L of 2,2&#x02032;-azino-bis (3-ethylbenzothiazoline-6-sulphonic) acid (ABTS) solution, giving a final extract concentration range of 250&#x02013;1.9531&#x02009;<italic>&#x003bc;</italic>g/mL. Ascorbic acid (Vitamin C) was used as control and after 1&#x02009;h incubation in the dark at room temperature; the optical densities were measured at 734&#x02009;nm. The radical scavenging activity fifty (RSA<sub>50</sub>, in %) was calculated [<xref rid="B23" ref-type="bibr">23</xref>].</p></sec><sec id="sec2.3.3"><title>2.3.3. Nitric Oxide Radical Scavenging Activity</title><p>Nitric oxide generated from sodium nitroprusside in aqueous solution interacts with oxygen to produce nitrite ions, measurable through the Griess reaction. The test was preformed according to Hossain and collaborators [<xref rid="B24" ref-type="bibr">24</xref>] with slight modifications. Briefly, in 75&#x02009;<italic>&#x003bc;</italic>L of sodium nitroprusside, 50&#x02009;<italic>&#x003bc;</italic>L of extract was added at different concentrations leading to a final extract concentration from 250 to 1.9531&#x02009;<italic>&#x003bc;</italic>g/mL. The mixture was then incubated at room temperature for 2 hours. The blank was prepared by replacing extract with ethanol. At the end of the incubation time, 1.25&#x02009;mL of Griess reagent (1% sulfanilamide in 5% phosphoric acid and 0.1% N-1-napthylethylenediamine dihydrochloride in water) were added, and the absorbance was recorded after 5&#x02009;min in the dark at 540&#x02009;nm. Inhibition percentages of the nitrite oxide generated were measured by comparing the absorbance values of test samples versus control. Ascorbic acid was used as a positive standard control in the study.</p></sec><sec id="sec2.3.4"><title>2.3.4. Ferric-Reducing Antioxidant Power (FRAP) Assay</title><p>The ferric reducing power was determined by the Fe<sup>3+</sup>-Fe<sup>2+</sup> transformation in the presence of the extract [<xref rid="B25" ref-type="bibr">25</xref>]. The Fe<sup>2+</sup> was monitored by measuring the formation of orthophenanthroline at 505&#x02009;nm. The extract (1000&#x02009;<italic>&#x003bc;</italic>g/mL) was twofold serially diluted with ethanol. 50&#x02009;<italic>&#x003bc;</italic>L of the diluted extract was mixed with 50&#x02009;<italic>&#x003bc;</italic>L of ferric chloride solution. After 15&#x02009;min of incubation in the dark at room temperature, 50&#x02009;<italic>&#x003bc;</italic>L of orthophenanthroline was added to obtain final extract concentrations ranging from 250 to 1.9531&#x02009;<italic>&#x003bc;</italic>g/mL (250, 125, 62.5, 31.25, 15.625, 7.8125, 3.9062, and 1.9531&#x02009;<italic>&#x003bc;</italic>g/mL). Hydroxylamine (NH<sub>2</sub>OH) was used as positive control, and the optical densities were measured at 505&#x02009;nm; each assay was done in triplicate. The Fe<sup>3+</sup>-reducing capacity (RC in %) was calculated, the reduction percentages were plotted against the logarithmic values of concentration of test samples, and a linear regression curve was established in order to calculate the inhibitory concentration 50 (IC<sub>50</sub>), which is the concentration of sample necessary to reduce 50% the total free Fe<sup>3+</sup> in Fe<sup>2+</sup> radical.</p></sec></sec><sec id="sec2.4"><title>2.4. Animals</title><p>Rats weighing 220&#x02009;&#x000b1;&#x02009;20&#x02009;g were used in the present study. They were obtained from the animal house of the Faculty of Science, University of Yaound&#x000e9; I (Cameroon). Animals were submitted to the standard diet established in this laboratory and received water <italic>ad libitum</italic>. All the procedures in the present study followed the principles of laboratory animal use and care of the &#x0201c;European community guidelines (EEC Directive 2010/63/EEC) and were approved by the &#x0201c;Animal Ethical committee&#x0201d; of the Faculty of Science, University of Yaound&#x000e9; I.</p></sec><sec id="sec2.5"><title>2.5. Induction of Type 2 Diabetes and Experimental Design</title><p>Type II diabetes was induced by the intraperitoneal injection of 110&#x02009;mg/kg of nicotinamide 15&#x02009;min prior intravenous (penile vein) injection of 55&#x02009;mg/kg streptozotocin in 0.9% of sodium chloride solution [<xref rid="B26" ref-type="bibr">26</xref>]. Diabetes was allowed to develop and to stabilize over a period of 2 weeks [<xref rid="B27" ref-type="bibr">27</xref>], animals with glycemia between 126 and 300&#x02009;mg/dL were considered as diabetic, and then they were subjected to the insulin resistance test. Diabetic animals were divided into 5 groups of 5 animals each and treated as follows: one group treated with distilled water (10&#x02009;mL/kg) named diabetic control, another group consisted to metformin 200&#x02009;mg/kg treated with metformin (200&#x02009;mg/kg), and three test groups that received the hydroethanolic bark extract of <italic>B. atroviridis</italic> at the respective dose of 50, 100, and 200&#x02009;mg/kg. To these different groups, one normal control group was made up of healthy rats, and receiving distilled water was added. Animals were orally treated for 15 days during which fasting blood glucose levels was recorded every five days from the tail's blood drop, using a glucometer (Accucheck Active). At the end of the treatment, animals were sacrificed under anaesthesia using ketamin (30&#x02009;mg/kg) and diazepam (10&#x02009;mg/kg). Blood sample of each animal was collected into EDTA tubes and dry tubes. The pancreas was harvested for oxidative stress and histomorphometry analysis.</p></sec><sec id="sec2.6"><title>2.6. Insulin Tolerance Test (ITT)</title><p>At the beginning and the end of the treatment, the insulin tolerance test was performed to evaluate the insulin sensitivity. A dose of 0.15&#x02009;IU/kg of semislow insulin was injected subcutaneously to diabetic rats prior to a 12&#x02009;h nonhydrated fasting as described by Patarr&#x000e3;o et al. [<xref rid="B28" ref-type="bibr">28</xref>] with slight modifications. The glycemia was measured after insulin injection (<italic>t</italic>&#x02009;=&#x02009;0&#x02009;min) and then successively after 15, 30, and 60&#x02009;min insulin injection. The slope of the linear decline in plasma glucose (<italic>K</italic><sub>ITT</sub>) was calculated according to the following formula: <italic>K</italic><sub>ITT</sub>&#x02009;=&#x02009;(0.693/<italic>T</italic><sub>1/2</sub>)&#x02009;&#x000d7;&#x02009;100 [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>]. <italic>T</italic><sub>1/2</sub> represents the half life of plasmatic glucose.</p></sec><sec id="sec2.7"><title>2.7. Haematological Analysis</title><p>EDTA blood sample collected from each animal was used to performed different blood parameters using the Sysmex hematometer 300 (Sysmex300, Germany).</p></sec><sec id="sec2.8"><title>2.8. Serum Inflammatory Parameter Analysis</title><p>Blood sample into dry tubes was centrifuged, and supernatant serum was analysed for measure of some inflammatory parameters such as TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, Il-6, and IL-10 using Quantikine Elisa kits (Germany).</p></sec><sec id="sec2.9"><title>2.9. Oxidative Stress Parameter Analysis and Histopathological Analysis of the Pancreas</title><p>The pancreas is the central organ involved in the pathogenesis of both type I and type II diabetes. To evaluate the oxidative stress balance in this organ, a part of the organ was homogenate in Tris HCL buffer (10%) and some markers of oxidative stress such as the rate of reduced glutathione and nitrites, and the activity of catalase enzyme were evaluated. Histomorphometry study of the remaining part of pancreas was performed after haematoxylin/eosin stain. The area of pancreatic islet was measured using software of area measurement (Image J. version 1.3).</p></sec><sec id="sec2.10"><title>2.10. Statistical Analysis</title><p>Results were expressed as mean&#x02009;&#x000b1;&#x02009;S.E.M. Statistical differences between control and treated groups were highlighted using one-way analysis of variance (ANOVA) followed by Turkey's multiple comparison test, and Student <italic>t</italic> test was used to compare in vitro anti-oxidant test using Graphpad Prism 7 software. <italic>P</italic> values less than 0.05 were considered as significant.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Phytochemical Qualitative Content</title><p>Qualitative analysis of the plant extract revealed the presence of alkaloids, flavonoids, phenols, tannins, triterpenes, steroids, saponins, and anthocyanins, whereas diterpenes, anthraquinone, glucosides, and coumarins were absent.</p></sec><sec id="sec3.2"><title>3.2. In Vitro Scavenging and Antioxidant Activities of <italic>B. atroviridis</italic></title><p>
<xref rid="tab1" ref-type="table">Table 1</xref> indicates the radical scavenging activities of <italic>B. atroviridis</italic> on DPPH and ABTS. The results show that <italic>B. atroviridis</italic> expresses better antioxidant activities compared to the control. The plant extract showed greater DPPH scavenging than vitamin C and its capacity to catch ABTS is closed to the ascorbic acid. By contrary, the extract exhibited poor NO scavenging effect than the known standard. Concerning the capacity of <italic>B. atroviridis</italic> to prevent the reduction of Fe<sup>3+</sup> to Fe<sup>2+</sup>, it appears that the plant extract was able to inhibit the transformation of Fe<sup>3+</sup> to Fe <sup>2+</sup> but lesser than hydroxylamine used as the standard.</p></sec><sec id="sec3.3"><title>3.3. Insulin Sensitivity Test</title><p>Fourteen days after the diabetes induction, insulin resistance was evaluated prior the beginning of the treatment. The administration of insulin to nicotinamide-/streptozotocin-induced diabetic rats failed to decrease the blood glucose levels (data not shown). <xref ref-type="fig" rid="fig1"> Figure 1</xref> shows the level of insulin index (<italic>K</italic><sub>iTT</sub>) before and after the treatment with the plant extract. Insulin injection provoked throughout the experimental period a drop of <italic>K</italic><sub>iTT</sub> by 53.90% (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>) as compared to normal rats. However, cumulative administration of the plant extract induced an improvement in insulin sensitivity characterized by a rise of <italic>K</italic><sub>iTT</sub>. The <italic>K</italic><sub>iTT</sub> value of diabetic rats remained significantly low at the end of the experimental period compared to normal rats (71.65%, <italic>P</italic> &#x0003c; 0.001). The extract induced a rise in <italic>K</italic><sub>iTT</sub> by 67.44%, 64.50%, and 60.84% at the respective doses of 50&#x02009;mg/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>).</p></sec><sec id="sec3.4"><title>3.4. Effect of Hydroethanolic Bark Extract of <italic>B. atroviridis</italic> on Body Weight Variation</title><p>
<xref ref-type="fig" rid="fig2">Figure 2</xref> presents the effects of <italic>B. atroviridis</italic> extract in nicotinamide-/streptozotocin-induced diabetic rats. The evolution of the body weight in the diabetic control group was lower compared to normal control. The administration of the plant extract for 15 days significantly improved the body weight gain compared to the diabetic control group only at the dose of 100&#x02009;mg/kg from day 9 to day 15. The plant extract at the doses of 50 and 200&#x02009;mg/kg did not significantly prevent the loss of body weight up to the end of the experiment. In contrary, the evolution of the body weight of animals in these groups, as in negative control group, was significantly low compared to the normal control.</p></sec><sec id="sec3.5"><title>3.5. Effects of Cumulative Administration of <italic>B. atroviridis</italic> Hydroethanolic Extract on Blood Glucose</title><p>The injection of nicotinamide prior to streptozotocin administration induced hyperglycemia by 66.98%. The glycemia remained high by 76.36% at the end of the treatment compared to normal control rats. The single daily administration of <italic>B. atroviridis</italic> for 2 weeks caused a significant decrease (<italic>P</italic> &#x0003c; 0.001) in blood glucose by 59.24% (50&#x02009;mg/kg), 67.05% (100&#x02009;mg/kg), and 70.52% (200&#x02009;mg/kg) compared to diabetic control (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Compared to their initial value (day 1), it was observed a significant decrease in blood glucose levels by 47.97%, 57.93%, and 62.22%, respectively, at the dose of 50, 100, and 200&#x02009;mg/kg. The decrease was gradual and significant from day 11. The plant extract at the dose of 200&#x02009;mg/kg brought back the glycemia towards the normal value. Metformin administration at the dose of 200&#x02009;mg/kg induced the decrease of blood glucose level by 70.52%.</p></sec><sec id="sec3.6"><title>3.6. Effects of Hydroethanolic Bark Extract of <italic>B. atroviridis</italic> in Some Haematological Parameters in Nicotinamide-/STZ-Induced Diabetes Rats</title><p>The induction of diabetes provoked anemia characterized by a significant drop of erythrocytes (RBC) count (31.85%, <italic>P</italic> &#x0003c; 0.01), hematocrit (HCT) (13.83%, <italic>P</italic> &#x0003c; 0.01), mean concentration of haemoglobin (MCH) by 38.26% (<italic>P</italic> &#x0003c; 0.01), mean corpuscular haemoglobin concentration (MCHC) (20.44%), and increase of mean corpuscular volume (MCV) (20.87%, <italic>P</italic> &#x0003c; 0.05) in the diabetic control group compared to normal control. In addition, the level of white blood cells increased (55.67%, <italic>P</italic> &#x0003c; 0.01), while the lymphocyte percentage decreased (24.96%, <italic>P</italic> &#x0003c; 0.01) (<xref rid="tab2" ref-type="table">Table 2</xref>). The rate of platelets was also significantly decreased in the diabetic control group (123.65%, <italic>P</italic> &#x0003c; 0.001) compared to the normal control. Oral administration of the plant extract induced a significant increase (at least at <italic>P</italic> &#x0003c; 0.01) of RBC, HCT, lymphocytes, and platelet rate.</p></sec><sec id="sec3.7"><title>3.7. Effect of Hydroethanolic Extract of <italic>B. atroviridis</italic> on Some Inflammatory Parameters</title><p>The administration of streptozotocin-/nicotinamide-induced diabetes is responsible of an increase rate of proinflammatory cytokines such as TNF-<italic>&#x003b1;</italic> (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>), IL-1<italic>&#x003b2;</italic> (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>), and IL-6 (<xref ref-type="fig" rid="fig4">Figure 4(c)</xref>) by 76.81%, 22.27%, and 32.04, respectively, while the increase rate of the anti-inflammatory factor IL-10 was 58.41% (<xref ref-type="fig" rid="fig4">Figure 4(d)</xref>) as compared to normal control. The treatment with hydroethanolic extract of <italic>B. atroviridis</italic> induced a significant decrease (<italic>P</italic> &#x0003c; 0.001) of TNF-<italic>&#x003b1;</italic> by 43.78%, 62.92%, and 58.38%, respectively, at the doses of 50, 100, and 200&#x02009;mg/kg. The extract also showed a significant decrease of IL-1<italic>&#x003b2;</italic> by 17.62% (50&#x02009;mg/kg), 33.68% (100&#x02009;mg/kg), and 29.53% (200&#x02009;mg/kg) after 15 days of treatment. The IL-10 concentration decreased by 65.08% (<italic>P</italic> &#x0003c; 0.001), 67.30% (<italic>P</italic> &#x0003c; 0.001), and 44.44% (<italic>P</italic> &#x0003c; 0.05) at the respective dose of 50, 100, and 200&#x02009;mg/kg. However, the plant extract failed to reduce (<italic>P</italic> &#x0003e; 0.05) IL-6 concentration whatever the dose is.</p></sec><sec id="sec3.8"><title>3.8. Effect of <italic>B. atroviridis</italic> Hydroethanolic Extract on Some Oxidative Stress Biomarkers in Pancreatic Tissue</title><p>
<xref ref-type="fig" rid="fig5">Figure 5</xref> expresses the effects of <italic>B. atroviridis</italic> on some oxidative stress parameters. The concentration of reduced glutathione significantly decreased (41.45%, <italic>P</italic> &#x0003c; 0.05) in diabetic rats, whereas the catalase activity significantly increased (36.34%, <italic>P</italic> &#x0003c; 0.001) compared to normal control. The administration of the plant extract for 15 days significantly decreased the catalase activity by 34.02% (50&#x02009;mg/kg), 39.95% (100&#x02009;mg/kg), and 25% (200&#x02009;mg/kg) in comparison with the diabetic control. The concentration of nitrites in the diabetic control group was higher than that of normal control (23.76%), and the plant extract significantly reversed this concentration by 53.68% and 50.08% (<italic>P</italic> &#x0003c; 0.001) at the doses of 50 and 100&#x02009;mg/kg, respectively, comparing to diabetic control rats.</p></sec><sec id="sec3.9"><title>3.9. Effects of <italic>B. atroviridis</italic> on Microarchitecture of Pancreas</title><p>
<xref ref-type="fig" rid="fig6">Figure 6</xref> describes the microarchitecture of the pancreas in the experimental animals. In diabetic control group, a significant reduction (78.08%, <italic>P</italic> &#x0003c; 0.001) in the Langerhans islets size was observed compared to normal control as shown in (a). The administration of the plant extract significantly increased the Langerhans islet size with dose-dependant effect at 50&#x02009;mg/kg (65.80%, <italic>P</italic> &#x0003c; 0.05), 100&#x02009;mg/kg (67.75%, <italic>P</italic> &#x0003c; 0.05), and 200&#x02009;mg/kg (72.3% <italic>P</italic> &#x0003c; 0.01).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>
<italic>B. atroviridis</italic> is largely used in Africa for many ailments [<xref rid="B13" ref-type="bibr">13</xref>], but its effect on some pathophysiological aspect in diabetic state was not scientifically studied up to now yet. In this study, nicotinamide-/streptozotocin-induced type II diabetes was characterized by a hyperglycemia, insulin resistance, anemia, leukocytosis, thrombocytopenia, inflammation, and structural damage of the pancreas. The administration of hydroethanolic extract of <italic>B. atroviridis</italic> bark for 15 days to diabetic rats efficiently corrected the blood glucose level with the marked effect at the dose of 200&#x02009;mg/kg, effective as the reference drug metformin (200&#x02009;mg/kg) at the end of the experimental period. The hypoglycemic effect observed could be due to the reduction of insulin resistance noted in treated rats. It is well known that metformin is equally acted by increasing the insulin sensitivity [<xref rid="B30" ref-type="bibr">30</xref>]. The plant extract may also act by stimulating the secretion of insulin and/or by increasing the insulin sensitivity [<xref rid="B31" ref-type="bibr">31</xref>]. These actions have been attested in the present study by the rise in insulin sensitivity index observed at the end of the treatment. Antihyperglycemic effect may be attributed to the presence of substances as flavonoids, alkaloids, saponin, tannins, and triterpenes contained in the extract. In addition, the determination of phytochemicals of hydroethanolic extract of <italic>B. artroviridis</italic> carried out by our research team revealed the presence of compounds such as myricetin and corilagin [<xref rid="B32" ref-type="bibr">32</xref>]. Corilagin acts by enhancing peripheral glucose utilization and stimulating pancreatic <italic>&#x003b2;</italic> cells to produce insulin [<xref rid="B33" ref-type="bibr">33</xref>] while myricetin enhances intracellular protein activity, encouraging glucose uptake consequently reduces insulin resistance [<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>]. These different compounds might react synergically to contribute to the observed hypoglycemic effect of the plant extract. Although the highest dose of the extract (200&#x02009;mg/kg) expressed the best activity, considering the hypoglycemic effect by the end of the treatment, the dose of 100&#x02009;mg/kg showed the most interesting effect since it presents progressive significant hypoglycemia activity from day 10 compared to the other treated groups.</p><p>Permanent hyperglycemia in diabetes condition leads to increase expression of inflammatory markers like IL-6 and TNF-<italic>&#x003b1;</italic> [<xref rid="B36" ref-type="bibr">36</xref>] as observed in this study. These cytokines are produced by immune and nonimmune cells when challenged by various environmental or inflammatory insults. Chronic exposure to proinflammatory mediators stimulates the activation of cytokine signaling proteins which ultimately block the interaction between the activation of insulin signaling pathway, biological function of pancreatic <italic>&#x003b2;</italic>-cells [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>], and conduce to insulin resistance [<xref rid="B39" ref-type="bibr">39</xref>]. Studies have also indicated that inflammatory cytokines such as IL-1<italic>&#x003b2;</italic>, TNF-<italic>&#x003b1;</italic>, and IL-6 which are increased in obesity and diabetes conditions modulate insulin signaling [<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>]. Cytokines such as IL-1<italic>&#x003b2;</italic> are upregulated in pancreatic islets of patients with type 2 diabetes and regulate numerous other cytokines and chemokines, consequently increasing its production in <italic>&#x003b2;</italic> cells, engendering a vicious cycle [<xref rid="B42" ref-type="bibr">42</xref>&#x02013;<xref rid="B44" ref-type="bibr">44</xref>]. A potential role of TNF-<italic>&#x003b1;</italic> has been reported in the pathogenesis of insulin resistance and type 2 diabetes [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B45" ref-type="bibr">45</xref>]. In the present study, the administration of nicotinamide/streptozotocin resulted in an insulin resistance and an increase in the rate of IL-1<italic>&#x003b2;</italic> and TNF-<italic>&#x003b1;</italic>, confirming their involvement in the pathogenesis of type II diabetes. Indeed, the plant extract may act as antagonist of TNF-<italic>&#x003b1;</italic> and IL-1<italic>&#x003b2;</italic> leading to the reduction of insulin resistance and to antihyperglycemia effects as observed in the study. In contrary to the study of Acharya et al. [<xref rid="B46" ref-type="bibr">46</xref>] where a depletion of IL-10 was observed, it was noticed in the present study, a high level of IL-10 in diabetic control group compared to normal control. In fact, IL-10 is a multiple effects cytokine acting in immunoregulation. It has been demonstrated in an in vitro study that IL-6 can cooperate with TGF-<italic>&#x003b2;</italic> to induce IL-10 production in Th17 cells [<xref rid="B47" ref-type="bibr">47</xref>]. <italic>Bridelia atroviridis</italic> was able to reduce significantly the production of IL-10 but not that of the IL-6 level. IL-6 is produced by different immune and nonimmune cells [<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>] suggesting the implication of other factors in its synthesis. The increase in IL-6 and TNF-<italic>&#x003b1;</italic> observed in diabetes state also acts as antierythropoietic factors expressed in the present study by the decrease in erythrocytes count, hematocrit, and mean corpuscular of haemoglobin values, which are some conventional signs of anemia [<xref rid="B36" ref-type="bibr">36</xref>]. The proinflammatory cytokine depletion induced by the extract could justify the protective effect from anemia. The leukocytosis observed in the diabetes control is well described as diabetes complications that could result from glycation end products activation, oxidative stress, and both macrovascular and microvascular injuries caused by hyperglycemia [<xref rid="B50" ref-type="bibr">50</xref>]. The decrease of leukocyte counts in treated groups indicates the ability of <italic>B. atroviridis</italic> extract to reduce diabetes complications. The decrease in lymphocyte count observed in diabetic control group has already been reported and could be due to apoptosis induced in hyperglycemia situation [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>]. The administration of the plant extract for 15 days significantly improved the cells level, indicating an inhibitory effect of <italic>B. atroviridis</italic> on proapoptosis factors or the scavenging properties against free radical agents in lymphocytes.</p><p>Enhanced platelet reactivity has been reported in type II diabetes. In fact, hyperglycemia contributes to glycation of platelet proteins leading to altered platelet count consequently increasing their reactivity [<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>]. However, after plant extract treatment, the level of platelet was significantly increased probably due to the improvement of the glycemia.</p><p>Reactive oxygen species (ROS) has been implicated in the mechanism of red blood cells damage [<xref rid="B55" ref-type="bibr">55</xref>] in the diabetic condition [<xref rid="B56" ref-type="bibr">56</xref>]. Previous studies reported the ROS generation in chronic high blood glucose levels, through several mechanisms including glucose autoxidation, the oxidation of protein [<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>], or the nonenzymatic glycation of protein [<xref rid="B59" ref-type="bibr">59</xref>] that exacerbate oxidative stress. It is known that streptozotocin induced hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) generation and DNA fragmentation in pancreatic islets [<xref rid="B60" ref-type="bibr">60</xref>] which could justify the increase in catalase activity observed in the present study.</p><p>The low concentration of GSH in diabetic control suggests a depletion of this antioxidant species [<xref rid="B61" ref-type="bibr">61</xref>]. The nitrite rate was high in the diabetic control group probably due to streptozotocin that reacts through the nitric oxide pathway to induce <italic>&#x003b2;</italic>-cells cytotoxicity effects [<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>]. The daily plant intake for 15 days significantly restored the catalase activity, GSH, and nitrite levels testifying the antioxidant capacity of <italic>B. atroviridis</italic> as seen in in vitro study. This antioxidant capacity of the extract could be assigned to its ability to scavenge free radicals or to provide a H<sup>+</sup> proton or an electron to the oxidant molecules, preventing devastating effects of diabetes in treated groups [<xref rid="B64" ref-type="bibr">64</xref>]. Likewise, these antioxidant properties might also due to the presence of lycophene, <italic>&#x003b2;</italic>-carotene, phenolics, and flavonoids which are potent antioxidant species identified in the leaf of <italic>B. atroviridis</italic> [<xref rid="B65" ref-type="bibr">65</xref>]. In addition, corilagin, an amorphous tannin, detected in the plant extract possesses antioxidant activity [<xref rid="B66" ref-type="bibr">66</xref>]. Histological study of the pancreas revealed a significant reduction in the size of Langerhans islet in the diabetic control group probably due to the oxidative reaction and cytotoxic effects of streptozotocin. The size of islets was significantly increased in the treated group suggesting that <italic>B. atroviridis</italic> extract could regenerate pancreatic <italic>&#x003b2;</italic>-cell, thus increasing the production of insulin, and may justify the hypoglycemic effect recorded in these groups.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>The investigation of effects of hydroethanolic extract of <italic>Bridelia atroviridis bark</italic> showed a decrease in hyperglycemia, inflammatory parameters, and a restoration in haematological parameters and an improvement in antioxidative status in the pancreas of nicotinamide-/streptozotocin-induced diabetes in rats. This is achieved by antidiabetic, anti-inflammatory, and antioxidant properties of the plant extract. <italic>Bridelia atroviridis</italic> could be a good candidate for the formulation of an antidiabetic drug plant based.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors are grateful to DAAD for financial support through the Yaound&#x000e9;-Bielefeld Graduate School for Natural Products with Antiparasitic and Antibacterial Activities (YaBINaPA) project, financially supported by Deutscher Akademischer Austauschdienst (DAAD) (grant no. 57316173).</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>IDF:</term><def><p>International Diabetes Federation</p></def></def-item><def-item><term>IL-1<italic>&#x003b2;</italic>:</term><def><p>Interleukin 1<italic>&#x003b2;</italic></p></def></def-item><def-item><term>IL-6:</term><def><p>Interleukin 6</p></def></def-item><def-item><term>TNF-<italic>&#x003b1;</italic>:</term><def><p>Tumor necrosis factor</p></def></def-item><def-item><term>IL-10:</term><def><p>Interleukin 10</p></def></def-item><def-item><term>ROS:</term><def><p>Reactive oxygen species</p></def></def-item><def-item><term>DPPH:</term><def><p>1,1-diphenyl-2- picrylhydrazyl</p></def></def-item><def-item><term>ABTS:</term><def><p>2,2&#x02032;-azino-bis (3-ethylbenzothiazoline-6-sulphonic) acid</p></def></def-item><def-item><term>FRAP:</term><def><p>Ferric reducing antioxidant power</p></def></def-item><def-item><term>NO:</term><def><p>Nitrite oxide</p></def></def-item><def-item><term>RSA:</term><def><p>Radical scavenging activity</p></def></def-item><def-item><term>IC<sub>50</sub>:</term><def><p>Inhibitory concentration 50</p></def></def-item><def-item><term>KITT:</term><def><p>Insulin tolerance test index</p></def></def-item><def-item><term>RBC:</term><def><p>Red blood cell</p></def></def-item><def-item><term>HGB:</term><def><p>Haemoglobin</p></def></def-item><def-item><term>HCT:</term><def><p>Haematocrit</p></def></def-item><def-item><term>PLT:</term><def><p>Platelets</p></def></def-item><def-item><term>WBC:</term><def><p>White blood cells</p></def></def-item><def-item><term>LYMP:</term><def><p>Lymphocytes</p></def></def-item><def-item><term>PLT:</term><def><p>Platelet.</p></def></def-item></def-list></glossary><sec sec-type="data-availability"><title>Data Availability</title><p>All data used to support the &#x0fb01;ndings of this study are available from the corresponding author upon request.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that there are no conflicts of interest.</p></sec><sec><title>Authors' Contributions</title><p>TD, FTN, and NS designed the study. RKG, JPD, and RF performed the haematological studies. CND, FTN, DPDD, and AK conducted the pharmacological and biochemical studies. CND, FTN, and RKG had been involved in drafting the manuscript. FTN and BNL performed the statistical analyses. CG, CND and NS harvested the plant sample and performed the plant extraction. All authors contributed substantially to the manuscript, read, and approved its final version.</p></sec><sec sec-type="supplementary-material" id="supplementary-material-1"><title>Supplementary Materials</title><supplementary-material content-type="local-data" id="supp-1"><label>Supplementary Materials</label><caption><p>The administration of the hydroethanolic extract from <italic>Bridelia atroviridis</italic> (Euphorbiaceae) to nicotinamide-/streptozotocin-induced diabetic rats improves blood glucose levels confirmed by the increase of <italic>K</italic><sub>iTT</sub> value, preventing them from anemia, leukocytopenia, and thrombocytopenia. The extract also exhibits significant regulation in the cytokine imbalance induced in diabetic conditions (Figure S1).</p></caption><media xlink:href="3160834.f1.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>B.</given-names></name><name><surname>Balomajumder</surname><given-names>C.</given-names></name><name><surname>Roy</surname><given-names>P.</given-names></name></person-group><article-title>Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats</article-title><source><italic toggle="yes">Food and Chemical Toxicology</italic></source><year>2008</year><volume>46</volume><issue>7</issue><fpage>2376</fpage><lpage>2383</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2008.03.020</pub-id><pub-id pub-id-type="other">2-s2.0-44749086549</pub-id><pub-id pub-id-type="pmid">18474411</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>N. H.</given-names></name><name><surname>Shaw</surname><given-names>J. E.</given-names></name><name><surname>Karuranga</surname><given-names>S.</given-names></name><etal/></person-group><article-title>IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>2018</year><volume>138</volume><fpage>271</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">29496507</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kooti</surname><given-names>W.</given-names></name><name><surname>Farokhipour</surname><given-names>M.</given-names></name><name><surname>Asadzadeh</surname><given-names>Z.</given-names></name><name><surname>Ashtary-Larky</surname><given-names>D.</given-names></name><name><surname>Asadi-Samani</surname><given-names>M.</given-names></name></person-group><article-title>The role of medicinal plants in the treatment of diabetes: a systematic review</article-title><source><italic toggle="yes">Electronic Physician</italic></source><year>2016</year><volume>8</volume><issue>1</issue><fpage>1832</fpage><lpage>1842</lpage><pub-id pub-id-type="doi">10.19082/1832</pub-id><pub-id pub-id-type="pmid">26955456</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favard</surname><given-names>P.</given-names></name><name><surname>Bonnal</surname><given-names>L.</given-names></name><name><surname>Tomen</surname><given-names>H.</given-names></name></person-group><article-title>Protection ET risque maladie: LE CAS DU. Paludisme au cameroun</article-title><source><italic toggle="yes">Assurance et Gestion des Risques</italic></source><year>2015</year><volume>82</volume><fpage>97</fpage><lpage>130</lpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antinori</surname><given-names>S.</given-names></name><name><surname>Galimberti</surname><given-names>L.</given-names></name><name><surname>Milazzo</surname><given-names>L.</given-names></name><name><surname>Corbellino</surname><given-names>M.</given-names></name></person-group><article-title>Biology of human malaria plasmodia including Plasmodium knowlesi</article-title><source><italic toggle="yes">Mediterranean Journal of Hematology and Infectious Diseases</italic></source><year>2012</year><volume>4</volume><issue>1</issue><pub-id pub-id-type="publisher-id">e2012013</pub-id><pub-id pub-id-type="doi">10.4084/mjhid.2012.013</pub-id><pub-id pub-id-type="other">2-s2.0-84870943598</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>M. J.</given-names></name><name><surname>Shallom</surname><given-names>S. J.</given-names></name><name><surname>Carlton</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14</article-title><source><italic toggle="yes">Nature</italic></source><year>2002</year><volume>419</volume><issue>6906</issue><fpage>531</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/nature01094</pub-id><pub-id pub-id-type="other">2-s2.0-0037015615</pub-id><pub-id pub-id-type="pmid">12368868</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donath</surname><given-names>M. Y.</given-names></name><name><surname>Dalmas</surname><given-names>&#x000c9;.</given-names></name><name><surname>Sauter</surname><given-names>N. S.</given-names></name><name><surname>B&#x000f6;ni-Schnetzler</surname><given-names>M.</given-names></name></person-group><article-title>Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity</article-title><source><italic toggle="yes">Cell Metabolism</italic></source><year>2013</year><volume>17</volume><issue>6</issue><fpage>860</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.05.001</pub-id><pub-id pub-id-type="other">2-s2.0-84878782369</pub-id><pub-id pub-id-type="pmid">23747245</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snow</surname><given-names>R. W.</given-names></name><name><surname>Guerra</surname><given-names>C. A.</given-names></name><name><surname>Noor</surname><given-names>A. M.</given-names></name><name><surname>Myint</surname><given-names>H. Y.</given-names></name><name><surname>Hay</surname><given-names>S. I.</given-names></name></person-group><article-title>The global distribution of clinical episodes of Plasmodium falciparum malaria</article-title><source><italic toggle="yes">Nature</italic></source><year>2005</year><volume>434</volume><issue>7030</issue><fpage>214</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1038/nature03342</pub-id><pub-id pub-id-type="other">2-s2.0-15044338866</pub-id><pub-id pub-id-type="pmid">15759000</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>I.</given-names></name><name><surname>Zimmerman</surname><given-names>P. A.</given-names></name><name><surname>Reeder</surname><given-names>J. C.</given-names></name></person-group><article-title>Plasmodium malariae and Plasmodium ovale&#x02014;the &#x0201c;bashful&#x0201d; malaria parasites</article-title><source><italic toggle="yes">Trends in Parasitology</italic></source><year>2007</year><volume>23</volume><issue>6</issue><fpage>278</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2007.04.009</pub-id><pub-id pub-id-type="other">2-s2.0-34248993025</pub-id><pub-id pub-id-type="pmid">17459775</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krotoski</surname><given-names>W. A.</given-names></name><name><surname>Killick-Kendrick</surname><given-names>R.</given-names></name><name><surname>Koontz</surname><given-names>L. C.</given-names></name><etal/></person-group><article-title>Demonstration of hypnozoites in sporozoite-transmitted plasmodium vivax infection</article-title><source><italic toggle="yes">The American Journal of Tropical Medicine and Hygiene</italic></source><year>1982</year><volume>31</volume><issue>6</issue><fpage>1291</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1982.31.1291</pub-id><pub-id pub-id-type="other">2-s2.0-0020455906</pub-id><pub-id pub-id-type="pmid">6816080</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>S. M.</given-names></name><name><surname>Cordeiro</surname><given-names>P. M.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Fonseca</surname><given-names>C. D. d.</given-names></name><name><surname>Vattimo</surname><given-names>M. d. F. F.</given-names></name></person-group><article-title>The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats</article-title><source><italic toggle="yes">Archives of Endocrinology and Metabolism</italic></source><year>2016</year><volume>60</volume><issue>5</issue><fpage>443</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1590/2359-3997000000188</pub-id><pub-id pub-id-type="other">2-s2.0-84993966993</pub-id><pub-id pub-id-type="pmid">27812607</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>W.</given-names></name><name><surname>Coatney</surname><given-names>G. R.</given-names></name></person-group><article-title>Relapse activity in sporozoite-induced infections with a west african strain of plasmodium ovale</article-title><source><italic toggle="yes">The American Journal of Tropical Medicine and Hygiene</italic></source><year>1971</year><volume>20</volume><issue>6</issue><fpage>825</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1971.20.825</pub-id><pub-id pub-id-type="other">2-s2.0-0015150156</pub-id><pub-id pub-id-type="pmid">5131690</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngueyem</surname><given-names>T. A.</given-names></name><name><surname>Brusotti</surname><given-names>G.</given-names></name><name><surname>Caccialanza</surname><given-names>G.</given-names></name><name><surname>Finzi</surname><given-names>P. V.</given-names></name></person-group><article-title>The genus Bridelia: a phytochemical and ethnopharmacological review</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2009</year><volume>124</volume><issue>3</issue><fpage>339</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.05.019</pub-id><pub-id pub-id-type="other">2-s2.0-67650690548</pub-id><pub-id pub-id-type="pmid">19477259</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adjanohoun</surname><given-names>J.</given-names></name><name><surname>Aboubakar</surname><given-names>N.</given-names></name><name><surname>Dramane</surname><given-names>K.</given-names></name><etal/></person-group><source><italic toggle="yes">Contribution to Ethnobotanical and Floristic Studies in Cameroon</italic></source><year>1996</year><publisher-loc>Addis Ababa, Ethiopia</publisher-loc><publisher-name>QAU/STRC</publisher-name></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adewale</surname><given-names>O.</given-names></name><name><surname>Oloyede</surname><given-names>O.</given-names></name></person-group><article-title>Hypoglycemic activity of aqueous extract of the bark of Bridelia ferruginea in normal and alloxan-induced diabetic rats</article-title><source><italic toggle="yes">Prime Research on Biotechnology</italic></source><year>2012</year><volume>2</volume><fpage>53</fpage><lpage>56</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omeh</surname><given-names>Y. N.</given-names></name><name><surname>Onoja</surname><given-names>S. O.</given-names></name><name><surname>Ezeja</surname><given-names>M. I.</given-names></name><name><surname>Okwor</surname><given-names>P. O.</given-names></name></person-group><article-title>Subacute antidiabetic and in vivo antioxidant effects of methanolic extract of Bridelia micrantha (Hochst Baill) leaf on alloxan-induced hyperglycaemic rats</article-title><source><italic toggle="yes">Journal of Complementary and Integrative Medicine</italic></source><year>2014</year><volume>11</volume><issue>2</issue><fpage>99</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1515/jcim-2013-0067</pub-id><pub-id pub-id-type="other">2-s2.0-84902470296</pub-id><pub-id pub-id-type="pmid">24760763</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokeng</surname><given-names>S.</given-names></name><name><surname>Rokeya</surname><given-names>B.</given-names></name><name><surname>Mostafa</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Antihyperglycemic effect of Bridelia ndellensis ethanol extract and fractions in streptozotocin-induced diabetic rats</article-title><source><italic toggle="yes">African Journal of Traditional, Complementary and Alternative Medicines</italic></source><year>2005</year><volume>2</volume><issue>2</issue><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v2i2.31107</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njamen</surname><given-names>D.</given-names></name><name><surname>Nkeh-Chungag</surname><given-names>B. N.</given-names></name><name><surname>Djiogue</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Antidiabetic properties of the methanolic extract of Bridelia grandis (Euphorbiacae) in ob/ob and db/db mice</article-title><source><italic toggle="yes">African Journal of Biotechnology</italic></source><year>2011</year><volume>10</volume><issue>13</issue><fpage>2520</fpage><lpage>2523</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anna</surname><given-names>W. K.</given-names></name><name><surname>Shripal</surname><given-names>M. C.</given-names></name></person-group><article-title>Antidiabetic activity of stem bark of Bridelia retusa (Linn.) Spreng</article-title><source><italic toggle="yes">Journal of Pharmacy Research</italic></source><year>2011</year><volume>4</volume><issue>4</issue><fpage>1149</fpage><lpage>1152</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Adebisi</surname><given-names>A. A.</given-names></name><name><surname>Lapido</surname><given-names>D. O.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Schmelzer</surname><given-names>G. H.</given-names></name><name><surname>Gurib-Fakim</surname><given-names>A.</given-names></name></person-group><article-title>Market survey of the barks of forest trees of phytomedicinal importance in southern Nigeria</article-title><source><italic toggle="yes">Plant Ressources of Tropical Africa 11(1).Medicinal Plant 1</italic></source><year>2008</year><publisher-loc>Leiden, Netherlands</publisher-loc><publisher-name>PROTA Foundation Wageningen, Netherlands/BlackhuysPublisher</publisher-name><fpage>123</fpage><lpage>125</lpage></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odebiyi</surname><given-names>O.</given-names></name><name><surname>Sofowora</surname><given-names>E. A.</given-names></name></person-group><article-title>Phytochemical screening of Nigerian medicinal plants II</article-title><source><italic toggle="yes">Lloydia</italic></source><year>1978</year><volume>41</volume><issue>3</issue><fpage>234</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">672462</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gul</surname><given-names>R.</given-names></name><name><surname>Jan</surname><given-names>S. U.</given-names></name><name><surname>Faridullah</surname><given-names>S.</given-names></name><name><surname>Sherani</surname><given-names>S.</given-names></name><name><surname>Jahan</surname><given-names>N.</given-names></name></person-group><article-title>Preliminary phytochemical screening, quantitative analysis of alkaloids, and antioxidant activity of crude plant extracts from ephedra intermedia indigenous to balochistan</article-title><source><italic toggle="yes">The Scientific World Journal</italic></source><year>2017</year><volume>2017</volume><fpage>7</fpage><pub-id pub-id-type="publisher-id">5873648</pub-id><pub-id pub-id-type="doi">10.1155/2017/5873648</pub-id><pub-id pub-id-type="other">2-s2.0-85016479773</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aadil</surname><given-names>K. R.</given-names></name><name><surname>Barapatre</surname><given-names>A.</given-names></name><name><surname>Sahu</surname><given-names>S.</given-names></name><name><surname>Jha</surname><given-names>H.</given-names></name><name><surname>Tiwary</surname><given-names>B. N.</given-names></name></person-group><article-title>Free radical scavenging activity and reducing power of Acacia nilotica wood lignin</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2014</year><volume>67</volume><fpage>220</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2014.03.040</pub-id><pub-id pub-id-type="other">2-s2.0-84897941639</pub-id><pub-id pub-id-type="pmid">24685465</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname><given-names>H.</given-names></name><name><surname>Ahmed</surname><given-names>T.</given-names></name><name><surname>Howlader</surname><given-names>S. I.</given-names></name><etal/></person-group><article-title>ISSN ( print ) in-vitro antioxidant potential from the leaves of punica granatum linn</article-title><source><italic toggle="yes">Grown in Bangladesh</italic></source><year>2012</year><volume>2</volume><issue>3</issue><fpage>160</fpage><lpage>166</lpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benzie</surname><given-names>I. F. F.</given-names></name><name><surname>Strain</surname><given-names>J. J.</given-names></name></person-group><article-title>The ferric reducing ability of plasma (FRAP) as a measure of &#x0201c;antioxidant power&#x0201d;: the FRAP assay</article-title><source><italic toggle="yes">Analytical Biochemistry</italic></source><year>1996</year><volume>239</volume><issue>1</issue><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1006/abio.1996.0292</pub-id><pub-id pub-id-type="other">2-s2.0-0030586361</pub-id><pub-id pub-id-type="pmid">8660627</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tond</surname><given-names>S. B.</given-names></name><name><surname>Fallah</surname><given-names>S.</given-names></name><name><surname>Salemi</surname><given-names>Z.</given-names></name><name><surname>Seifi</surname><given-names>M.</given-names></name></person-group><article-title>Influence of mulberry leaf extract on serum adiponectin, visfatin and lipid profile levels in type 2 diabetic rats</article-title><source><italic toggle="yes">Brazilian Archives of Biology and Technology</italic></source><year>2016</year><volume>59</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1590/1678-4324-2016160297</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>O. M.</given-names></name><name><surname>Moneim</surname><given-names>A. A.</given-names></name><name><surname>Yazid</surname><given-names>I. A.</given-names></name><name><surname>Mahmoud</surname><given-names>A. M.</given-names></name></person-group><article-title>Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats</article-title><source><italic toggle="yes">Diabetologia Croatica</italic></source><year>2010</year><volume>39</volume><issue>1</issue><fpage>15</fpage><lpage>35</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patarr&#x000e3;o</surname><given-names>R. S.</given-names></name><name><surname>Lautt</surname><given-names>W. W.</given-names></name><name><surname>Macedo</surname><given-names>M. P.</given-names></name></person-group><article-title>Assessment of methods and indexes of insulin sensitivity. Revista Portuguesa de Endocrinologia</article-title><source><italic toggle="yes">Diabetese Metabolismo</italic></source><year>2014</year><volume>9</volume><issue>1</issue><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.rpedm.2013.10.004</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngueguim</surname><given-names>F. T.</given-names></name><name><surname>Esse</surname><given-names>E. C.</given-names></name><name><surname>Dzeufiet</surname><given-names>P. D. D.</given-names></name><etal/></person-group><article-title>Oxidised palm oil and sucrose induced hyperglycemia in normal rats: effects of sclerocarya birrea stem barks aqueous extract</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2015</year><volume>16</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s12906-016-1009-0</pub-id><pub-id pub-id-type="other">2-s2.0-84956603118</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><collab>ADA</collab><article-title>Standards of medical Care in diabetes</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2016</year><volume>39</volume><issue>1</issue><fpage>1</fpage><lpage>122</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudasinghe</surname><given-names>H. P.</given-names></name><name><surname>Peiris</surname><given-names>D. C.</given-names></name></person-group><article-title>Hypoglycemic and hypolipidemic activity of aqueous leaf extract of Passiflora suberosa L</article-title><source><italic toggle="yes">Peer-Reviewed Scientific Mega Journal</italic></source><year>2018</year><volume>6</volume><pub-id pub-id-type="publisher-id">e4389</pub-id><pub-id pub-id-type="doi">10.7717/peerj.4389</pub-id><pub-id pub-id-type="other">2-s2.0-85042349171</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djouwoug</surname><given-names>C. N.</given-names></name><name><surname>Gounoue</surname><given-names>R. K.</given-names></name><name><surname>Ngueguim</surname><given-names>F. T.</given-names></name><etal/></person-group><article-title>In vitro and in vivo antiplasmodial activity of hydroethanolic bark extract of Bridelia atroviridis m&#x000fc;ll. Arg. (Euphorbiaceae) and lc-ms-based phytochemical analysis</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2021</year><volume>266</volume><pub-id pub-id-type="doi">10.1016/j.jep.2020.113424</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nandini</surname><given-names>H. S.</given-names></name><name><surname>Naik</surname><given-names>P. R.</given-names></name></person-group><article-title>Action of corilagin on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats</article-title><source><italic toggle="yes">Chemico-Biological Interactions</italic></source><year>2019</year><volume>299</volume><fpage>186</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2018.12.012</pub-id><pub-id pub-id-type="other">2-s2.0-85059195598</pub-id><pub-id pub-id-type="pmid">30582900</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taheri</surname><given-names>Y.</given-names></name><name><surname>Suleria</surname><given-names>H. A. R.</given-names></name><name><surname>Martins</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications</article-title><source><italic toggle="yes">BMC Complementary Medicine and Therapies</italic></source><year>2020</year><volume>20</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s12906-020-03033-z</pub-id><pub-id pub-id-type="pmid">32020859</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aminzadeh</surname><given-names>A.</given-names></name><name><surname>Bashiri</surname><given-names>H.</given-names></name></person-group><article-title>Myricetin ameliorates high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells</article-title><source><italic toggle="yes">Cell Biochemistry and Function</italic></source><year>2020</year><volume>38</volume><issue>1</issue><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/cbf.3442</pub-id><pub-id pub-id-type="pmid">31691320</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baisakhiya</surname><given-names>S.</given-names></name><name><surname>Garg</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name></person-group><article-title>Anemia in patients with type II diabetes mellitus with and without diabetic retinopathy</article-title><source><italic toggle="yes">International Journal of Medical Science and Public Health</italic></source><year>2017</year><volume>6</volume><issue>2</issue><fpage>p. 1</fpage><pub-id pub-id-type="doi">10.5455/ijmsph.2017.03082016604</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gentilini</surname><given-names>M.</given-names></name><name><surname>Duflo</surname><given-names>B.</given-names></name></person-group><source><italic toggle="yes">Le Paludisme Dans M&#x000e9;decine Tropicale</italic></source><year>1990</year><publisher-loc>Paris, France</publisher-loc><publisher-name>Flammarion</publisher-name></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Good</surname><given-names>M. F.</given-names></name><name><surname>Doolan</surname><given-names>D. L.</given-names></name></person-group><article-title>Malaria vaccine design: immunological considerations</article-title><source><italic toggle="yes">Immunity</italic></source><year>2010</year><volume>33</volume><issue>4</issue><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.005</pub-id><pub-id pub-id-type="other">2-s2.0-77958482582</pub-id><pub-id pub-id-type="pmid">21029965</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>K.</given-names></name><name><surname>Akash</surname><given-names>M. S. H.</given-names></name></person-group><article-title>Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?</article-title><source><italic toggle="yes">Journal of Biomedical Science</italic></source><year>2016</year><volume>23</volume><issue>1</issue><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s12929-016-0303-y</pub-id><pub-id pub-id-type="other">2-s2.0-85001018467</pub-id><pub-id pub-id-type="pmid">26753721</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>C.</given-names></name><name><surname>Rao</surname><given-names>X.</given-names></name><name><surname>Zhong</surname><given-names>J.</given-names></name></person-group><article-title>Role of T Lymphocytes in type 2 diabetes and diabetes-associated inflammation</article-title><source><italic toggle="yes">Journal of Diabetes Research</italic></source><year>2017</year><volume>2017</volume><fpage>6</fpage><pub-id pub-id-type="publisher-id">6494795</pub-id><pub-id pub-id-type="doi">10.1155/2017/6494795</pub-id><pub-id pub-id-type="other">2-s2.0-85013344047</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>H. V.</given-names></name><name><surname>Luu</surname><given-names>N. K.</given-names></name><name><surname>Son</surname><given-names>H. A.</given-names></name><etal/></person-group><article-title>Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus</article-title><source><italic toggle="yes">Journal of Diabetes Investigation</italic></source><year>2017</year><volume>8</volume><issue>3</issue><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1111/jdi.12579</pub-id><pub-id pub-id-type="other">2-s2.0-84997830702</pub-id><pub-id pub-id-type="pmid">27684566</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;ni-Schnetzler</surname><given-names>M.</given-names></name><name><surname>Thorne</surname><given-names>J.</given-names></name><name><surname>Parnaud</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Increased interleukin (IL)-1<italic>&#x003b2;</italic> messenger ribonucleic acid expression in <italic>&#x003b2;</italic>-cells of individuals with type 2 diabetes and regulation of IL-1<italic>&#x003b2;</italic> in human islets by glucose and autostimulation</article-title><source><italic toggle="yes">The Journal of Clinical Endocrinology &#x00026; Metabolism</italic></source><year>2008</year><volume>93</volume><issue>10</issue><fpage>4065</fpage><lpage>4074</lpage><pub-id pub-id-type="pmid">18664535</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pages</surname><given-names>F.</given-names></name><name><surname>Orlandipradines</surname><given-names>E.</given-names></name><name><surname>Corbel</surname><given-names>V.</given-names></name></person-group><article-title>Vecteurs du paludisme: biologie, diversit&#x000e9;, contr&#x000f4;le et protection individuelle</article-title><source><italic toggle="yes">M&#x000e9;decine et Maladies Infectieuses</italic></source><year>2007</year><volume>37</volume><issue>3</issue><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.medmal.2006.10.009</pub-id><pub-id pub-id-type="other">2-s2.0-33947715603</pub-id><pub-id pub-id-type="pmid">17306484</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehses</surname><given-names>J. A.</given-names></name><name><surname>Lacraz</surname><given-names>G.</given-names></name><name><surname>Giroix</surname><given-names>M.-H.</given-names></name><etal/></person-group><article-title>IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences</italic></source><year>2009</year><volume>106</volume><issue>33</issue><fpage>13998</fpage><lpage>14003</lpage><pub-id pub-id-type="doi">10.1073/pnas.0810087106</pub-id><pub-id pub-id-type="other">2-s2.0-69549098032</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>M.</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>L.</given-names></name><name><surname>Caicedo</surname><given-names>J. C.</given-names></name><etal/></person-group><article-title>Composition and biting activity ofAnopheles (Diptera: Culicidae) in the amazon region of Colombia</article-title><source><italic toggle="yes">Journal of Medical Entomology</italic></source><year>2009</year><volume>46</volume><issue>2</issue><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1603/033.046.0215</pub-id><pub-id pub-id-type="other">2-s2.0-63749096566</pub-id><pub-id pub-id-type="pmid">19351081</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>A.</given-names></name><name><surname>Thakur</surname><given-names>S.</given-names></name><name><surname>Muddapur</surname><given-names>M.</given-names></name></person-group><article-title>Effect of scaling and root planing on serum interleukin-10 levels and glycemic control in chronic periodontitis and type 2 diabetes mellitus</article-title><source><italic toggle="yes">Journal of Indian Society of Periodontology</italic></source><year>2015</year><volume>19</volume><issue>2</issue><fpage>p. 188</fpage><pub-id pub-id-type="doi">10.4103/0972-124x.148644</pub-id><pub-id pub-id-type="other">2-s2.0-84929336673</pub-id><pub-id pub-id-type="pmid">26015670</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J.-O.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>Q.</given-names></name></person-group><article-title>Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation</article-title><source><italic toggle="yes">Journal of Autoimmunity</italic></source><year>2013</year><volume>40</volume><fpage>28</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2012.07.009</pub-id><pub-id pub-id-type="other">2-s2.0-84873742482</pub-id><pub-id pub-id-type="pmid">22921334</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>R.</given-names></name></person-group><article-title>Cerebral malaria</article-title><source><italic toggle="yes">The Journal of the Association of Physicians of India</italic></source><year>2000</year><volume>48</volume><issue>10</issue><fpage>1004</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">11200901</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristiansen</surname><given-names>O. P.</given-names></name><name><surname>Mandrup-Poulsen</surname><given-names>T.</given-names></name></person-group><article-title>Interleukin-6 and diabetes: the good, the bad, or the indifferent?</article-title><source><italic toggle="yes">Diabetes</italic></source><year>2005</year><volume>54</volume><issue>2</issue><fpage>S114</fpage><lpage>S124</lpage><pub-id pub-id-type="doi">10.2337/diabetes.54.suppl_2.s114</pub-id><pub-id pub-id-type="other">2-s2.0-33644755633</pub-id><pub-id pub-id-type="pmid">16306329</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>S.</given-names></name><name><surname>Jafarian-Kerman</surname><given-names>S. R.</given-names></name><name><surname>Salari</surname><given-names>F.</given-names></name><name><surname>Rohani</surname><given-names>F.</given-names></name></person-group><article-title>Association between diabetes complications and leukocyte counts in Iranian patients</article-title><source><italic toggle="yes">Journal of Inflammation Research</italic></source><year>2012</year><volume>5</volume><issue>1</issue><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.2147/jir.s26917</pub-id><pub-id pub-id-type="other">2-s2.0-84856771979</pub-id><pub-id pub-id-type="pmid">22334791</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otton</surname><given-names>R.</given-names></name><name><surname>Soriano</surname><given-names>F.</given-names></name><name><surname>Verlengia</surname><given-names>R.</given-names></name><name><surname>Curi</surname><given-names>R.</given-names></name></person-group><article-title>Diabetes induces apoptosis in lymphocytes</article-title><source><italic toggle="yes">Journal of Endocrinology</italic></source><year>2004</year><volume>182</volume><issue>1</issue><fpage>145</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1677/joe.0.1820145</pub-id><pub-id pub-id-type="other">2-s2.0-4043116323</pub-id><pub-id pub-id-type="pmid">15225139</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arya</surname><given-names>A.</given-names></name><name><surname>Garg</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Meena</surname><given-names>L.</given-names></name><name><surname>Tripathi</surname><given-names>K.</given-names></name></person-group><article-title>Estimation of lymphocyte apoptosis in patients with chronic, non healing diabetic foot ulcer</article-title><source><italic toggle="yes">International Journal of Medical Science and Public Health</italic></source><year>2013</year><volume>2</volume><issue>4</issue><fpage>p. 811</fpage><pub-id pub-id-type="doi">10.5455/ijmsph.2013.100620132</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinik</surname><given-names>A. I.</given-names></name><name><surname>Erbas</surname><given-names>T.</given-names></name><name><surname>Park</surname><given-names>T. S.</given-names></name><name><surname>Nolan</surname><given-names>R.</given-names></name><name><surname>Pittenger</surname><given-names>G. L.</given-names></name></person-group><article-title>Platelet dysfunction in type 2 diabetes</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2001</year><volume>24</volume><issue>8</issue><fpage>1476</fpage><lpage>1485</lpage><pub-id pub-id-type="doi">10.2337/diacare.24.8.1476</pub-id><pub-id pub-id-type="other">2-s2.0-0035433149</pub-id><pub-id pub-id-type="pmid">11473089</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shilpi</surname><given-names>K.</given-names></name><name><surname>Potekar</surname><given-names>R. M.</given-names></name></person-group><article-title>A study of platelet indices in type 2 diabetes mellitus patients</article-title><source><italic toggle="yes">Indian Journal of Hematology and Blood Transfusion</italic></source><year>2018</year><volume>34</volume><issue>1</issue><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1007/s12288-017-0825-9</pub-id><pub-id pub-id-type="other">2-s2.0-85019014078</pub-id><pub-id pub-id-type="pmid">29398809</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>G.</given-names></name><name><surname>Kamath</surname><given-names>U.</given-names></name><name><surname>Raghothama</surname><given-names>C.</given-names></name><name><surname>Pradeep</surname><given-names>K. S.</given-names></name><name><surname>Rao</surname><given-names>P.</given-names></name></person-group><article-title>Maternal and fetal indicators of oxidative stress in various obstetric complications</article-title><source><italic toggle="yes">Indian Journal of Clinical Biochemistry</italic></source><year>2003</year><volume>18</volume><issue>2</issue><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1007/bf02867371</pub-id><pub-id pub-id-type="other">2-s2.0-0042933849</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>D. K.</given-names></name><name><surname>Winocour</surname><given-names>P.</given-names></name><name><surname>Farrington</surname><given-names>K.</given-names></name></person-group><article-title>Erythropoietic stress and anemia in diabetes mellitus</article-title><source><italic toggle="yes">Nature Reviews Endocrinology</italic></source><year>2009</year><volume>5</volume><issue>4</issue><fpage>204</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2009.17</pub-id><pub-id pub-id-type="other">2-s2.0-67649379280</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rignon</surname><given-names>J. L.</given-names></name><name><surname>Druilhe</surname><given-names>P.</given-names></name></person-group><article-title>Immune mechanisms underlying the premunition against Plasmodium falciparum malaria</article-title><source><italic toggle="yes">Mem&#x000f3;rias Do Instituto Oswaldo Cruz</italic></source><year>1994</year><volume>89</volume><issue>2</issue><fpage>51</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1590/s0074-02761994000600013</pub-id><pub-id pub-id-type="other">2-s2.0-17744420399</pub-id><pub-id pub-id-type="pmid">7565132</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maritim</surname><given-names>A. C.</given-names></name><name><surname>Sanders</surname><given-names>R. A.</given-names></name><name><surname>Watkins</surname><given-names>J. B.</given-names></name></person-group><article-title>Diabetes, oxidative stress, and antioxidants: a review</article-title><source><italic toggle="yes">Journal of Biochemical and Molecular Toxicology</italic></source><year>2003</year><volume>17</volume><issue>1</issue><fpage>24</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1002/jbt.10058</pub-id><pub-id pub-id-type="other">2-s2.0-0037253073</pub-id><pub-id pub-id-type="pmid">12616644</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obi</surname><given-names>R.</given-names></name><name><surname>Okangba</surname><given-names>C.</given-names></name><name><surname>Nwanebu</surname><given-names>F.</given-names></name><name><surname>Ndubuisi</surname><given-names>U.</given-names></name><name><surname>Orji</surname><given-names>N.</given-names></name></person-group><article-title>Premunition in Plasmodium falciparum malaria</article-title><source><italic toggle="yes">African Journal of Biotechnology</italic></source><year>2010</year><volume>9</volume><issue>10</issue><fpage>1397</fpage><lpage>1401</lpage></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronoff</surname><given-names>S. L.</given-names></name><name><surname>Berkowitz</surname><given-names>K.</given-names></name><name><surname>Shreiner</surname><given-names>B.</given-names></name><name><surname>Want</surname><given-names>L.</given-names></name></person-group><article-title>Glucose metabolism and regulation: beyond insulin and glucagon</article-title><source><italic toggle="yes">Diabetes Spectrum</italic></source><year>2004</year><volume>17</volume><issue>3</issue><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.2337/diaspect.17.3.183</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broberger</surname><given-names>C.</given-names></name></person-group><article-title>Brain regulation of food intake and appetite: molecules and networks</article-title><source><italic toggle="yes">Journal of Internal Medicine</italic></source><year>2005</year><volume>258</volume><issue>4</issue><fpage>301</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2005.01553.x</pub-id><pub-id pub-id-type="other">2-s2.0-25444482392</pub-id><pub-id pub-id-type="pmid">16164570</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szkudelski</surname><given-names>T.</given-names></name></person-group><article-title>Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model</article-title><source><italic toggle="yes">Experimental Biology and Medicine</italic></source><year>2012</year><volume>237</volume><issue>5</issue><fpage>481</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1258/ebm.2012.011372</pub-id><pub-id pub-id-type="other">2-s2.0-84862006013</pub-id><pub-id pub-id-type="pmid">22619373</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>D. F.</given-names></name><name><surname>Oyer</surname><given-names>P. E.</given-names></name></person-group><article-title>The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences</italic></source><year>1967</year><volume>57</volume><issue>2</issue><fpage>p. 473</fpage><pub-id pub-id-type="doi">10.1073/pnas.57.2.473</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moukette</surname><given-names>B. M.</given-names></name><name><surname>Ama Moor</surname><given-names>V. J.</given-names></name><name><surname>Biapa Nya</surname><given-names>C. P.</given-names></name><etal/></person-group><article-title>Antioxidant and synergistic antidiabetic activities of a three-plant preparation used in Cameroon folk medicine</article-title><source><italic toggle="yes">International Scholarly Research Notices</italic></source><year>2017</year><volume>2017</volume><fpage>7</fpage><pub-id pub-id-type="publisher-id">9501675</pub-id><pub-id pub-id-type="doi">10.1155/2017/9501675</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokefun</surname><given-names>O. O.</given-names></name><name><surname>Eleyowo</surname><given-names>O. O.</given-names></name></person-group><article-title>In vitro Antioxidant and Antibacterial activity of Bridelia atroviridis</article-title><source><italic toggle="yes">Arasado</italic></source><year>2017</year><volume>2</volume><issue>4</issue><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakubu</surname><given-names>O. F.</given-names></name><name><surname>Adebayo</surname><given-names>A. H.</given-names></name><name><surname>Iweala</surname><given-names>E. E.</given-names></name><name><surname>Adelani</surname><given-names>I. B.</given-names></name><name><surname>Ishola</surname><given-names>T. A.</given-names></name><name><surname>Zhang</surname><given-names>Y.-J.</given-names></name></person-group><article-title>Anti-inflammatory and antioxidant activities of fractions and compound from Ricinodendron heudelotii (Baill.)</article-title><source><italic toggle="yes">Heliyon</italic></source><year>2019</year><volume>5</volume><issue>11</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e02779</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Insulin index before treatment (a) and the effects of <italic>B. atroviridis</italic> on insulin index (b) after 2 weeks of treatment. Each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM (<italic>n</italic>&#x02009;=&#x02009;5); ##<italic>P</italic> &#x0003c; 0.01 and ###<italic>P</italic> &#x0003c; 0.001 indicate significant difference between diabetic and normal control and <italic>&#x02217;&#x02217;&#x02217;P</italic> &#x0003c; 0.001 indicates significant difference between diabetic control and treated groups.</p></caption><graphic xlink:href="ECAM2020-3160834.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effects of <italic>B. atroviridis</italic> extract on body weight variation. Each point represents mean&#x02009;&#x000b1;&#x02009;SEM (<italic>n</italic>&#x02009;=&#x02009;5). #<italic>P</italic> &#x0003c; 0.05 and ###<italic>P</italic> &#x0003c; 0.001: significant difference compared to normal control. <italic>&#x02217;P</italic> &#x0003c; 0.05 and <italic>&#x02217;&#x02217;P</italic> &#x0003c; 0.01: significant difference related to diabetic control. Normal control&#x02009;=&#x02009;healthy animals treated with distilled water (10&#x02009;mL/kg). Diabetic control&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with distilled water (10&#x02009;mL/kg). Metformin 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with metformin at the dose of 200&#x02009;mg/kg. <italic>B. atroviridis</italic> 50&#x02009;mg/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with <italic>B. atroviridis</italic> extract at the doses of 50&#x02009;m/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg, respectively.</p></caption><graphic xlink:href="ECAM2020-3160834.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Effects of <italic>B. atroviridis</italic> on the evolution of glycemia. Each point represents mean&#x02009;&#x000b1;&#x02009;ESM, <italic>n</italic>&#x02009;=&#x02009;5. <italic>&#x02217;P</italic> &#x0003c; 0.05, <italic>&#x02217;&#x02217;P</italic> &#x0003c; 0.01, and <italic>&#x02217;&#x02217;&#x02217;P</italic> &#x0003c; 0.001 indicate significant difference between diabetic control and treat groups at a given day. ##<italic>P</italic> &#x0003c; 0.01 and ###<italic>P</italic> &#x0003c; 0.001 indicate significant difference between normal control and diabetic control and at a given day. $<italic>P</italic> &#x0003c; 0.01 and $$$<italic>P</italic> &#x0003c; 0.001 indicate significant difference between normal control and treated groups at a given day.</p></caption><graphic xlink:href="ECAM2020-3160834.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effects of <italic>B. atroviridis</italic> on TNF-<italic>&#x003b1;</italic> (a), IL-1<italic>&#x003b2;</italic> (b), IL-6 (c), and IL-10 (d) concentrations in nicotinamide-/streptozotocin-induced-diabetic rats. Each bar represents the mean&#x02009;&#x000b1;&#x02009;SEM (<italic>n</italic>&#x02009;=&#x02009;5). #<italic>P</italic> &#x0003c; 0.05, ##<italic>P</italic> &#x0003c; 0.01, and ###<italic>P</italic> &#x0003c; 0.001 indicate significant difference between diabetic and normal control and <italic>&#x02217;P</italic> &#x0003c; &#x02009;0.05, <italic>&#x02217;P</italic> &#x0003c; 0.01, and <italic>&#x02217;&#x02217;&#x02217;P</italic> &#x0003c; 0.001 indicate significant difference between diabetic control and treated groups. Normal control&#x02009;=&#x02009;healthy animals treated with distilled water (10&#x02009;mL/kg). Diabetic control&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with distilled water (10&#x02009;mL/kg). Metformin 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with metformin at the dose of 200&#x02009;mg/kg. <italic>B. atroviridis</italic> 50&#x02009;mg/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with <italic>B. atroviridis</italic> extract at the doses of 50&#x02009;m/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg, respectively. TNF-<italic>&#x003b1;</italic>&#x02009;=&#x02009;tumor necrosis factor alpha, IL-1<italic>&#x003b2;</italic>&#x02009;=&#x02009;interleukin 1 beta, IL-6&#x02009;=&#x02009;interleukin 6, and IL-10&#x02009;=&#x02009;interleukin 10.</p></caption><graphic xlink:href="ECAM2020-3160834.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Effects of <italic>B. atroviridis</italic> on the rate of reduced glutathione (a), catalase activity (b), and rate of nitrites (c) in the pancreas. Bars represent mean&#x02009;&#x000b1;&#x02009;SEM (<italic>n</italic>&#x02009;=&#x02009;5). ##<italic>P</italic> &#x0003c; 0.01 and ###<italic>P</italic> &#x0003c; 0.001: significant difference compared to normal control. <italic>&#x02217;P</italic> &#x0003c; 0.05, <italic>&#x02217;&#x02217;P</italic> &#x0003c; 0.01, and <italic>&#x02217;&#x02217;&#x02217;P</italic> &#x0003c; 0.001: significant difference related to diabetic control. Normal control&#x02009;=&#x02009;healthy animals treated with distilled water (10&#x02009;mL/kg). Diabetic control&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with distilled water (10&#x02009;mL/kg). Metformin 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with metformin at the dose of 200&#x02009;mg/kg. <italic>B. atroviridis</italic> 50&#x02009;mg/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with <italic>B. atroviridis</italic> extract at the doses of 50&#x02009;m/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg, respectively.</p></caption><graphic xlink:href="ECAM2020-3160834.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Effects of <italic>B. atroviridis</italic> on the size of Langerhans islets (a) and the microarchitecture of the pancreas in diabetic rats (b). Each bar represents mean&#x02009;&#x000b1;&#x02009;SEM, <italic>n</italic> (number of Langerhans islets observed per animal)&#x02009;=&#x02009;10; ##<italic>P</italic> &#x0003c; 0.001 indicates significant difference between diabetic and normal control <italic>&#x02217;P</italic> &#x0003c; 0.05 and <italic>&#x02217;&#x02217;P</italic> &#x0003c; 0.01 indicate significant difference between diabetic control and treated groups. LI: Langerhans islet, Ac: Acini. Normal control&#x02009;=&#x02009;healthy animals treated with distilled water (10&#x02009;mL/kg). Diabetic control&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with distilled water (10&#x02009;mL/kg). Metformin 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with metformin at the dose of 200&#x02009;mg/kg. <italic>B. atroviridis</italic> 50&#x02009;mg/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with <italic>B. atroviridis</italic> extract at the dose of 50&#x02009;m/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg, respectively.</p></caption><graphic xlink:href="ECAM2020-3160834.006"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Scavenging activity or reducing power of <italic>B. atroviridis</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">IC<sub>50</sub> (<italic>&#x003bc;</italic>g/mL)</th><th align="center" rowspan="1" colspan="1">Positive control (<italic>&#x003bc;</italic>g/mL)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">DPPH</td><td align="center" rowspan="1" colspan="1">3.99&#x02009;&#x000b1;&#x02009;0.35<italic>&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">8.93&#x02009;&#x000b1;&#x02009;0.037</td></tr><tr><td align="left" rowspan="1" colspan="1">ABTS</td><td align="center" rowspan="1" colspan="1">3.23&#x02009;&#x000b1;&#x02009;0.65</td><td align="center" rowspan="1" colspan="1">2.71&#x02009;&#x000b1;&#x02009;0.080</td></tr><tr><td align="left" rowspan="1" colspan="1">NO</td><td align="center" rowspan="1" colspan="1">126.98&#x02009;&#x000b1;&#x02009;4.61<sup>$$$</sup></td><td align="center" rowspan="1" colspan="1">35.40&#x02009;&#x000b1;&#x02009;0.049</td></tr><tr><td align="left" rowspan="1" colspan="1">FRAP</td><td align="center" rowspan="1" colspan="1">27.97&#x02009;&#x000b1;&#x02009;0.25<sup>$$</sup></td><td align="center" rowspan="1" colspan="1">14.05&#x02009;&#x000b1;&#x02009;0.38</td></tr></tbody></table><table-wrap-foot><fn><p>IC<sub>50</sub>&#x02009;=&#x02009;inhibitory concentration 50; <sup><italic>&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.05&#x02009;=&#x02009;more active compared to the reference; <sup>$$</sup><italic>P</italic> &#x0003c; 0.01 and <sup>$$$</sup><italic>P</italic> &#x0003c; 0.001 less active compared to the reference.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Effects of hydroethanolic extract of <italic>Bridelia atroviridis</italic> on the variation of haematological parameters in nicotinamide-/STZ-induced diabetic rats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">Normal control</th><th align="center" rowspan="1" colspan="1">Diabetic control</th><th align="center" rowspan="1" colspan="1">Metformin 200&#x02009;mg /kg</th><th align="center" rowspan="1" colspan="1">
<italic>B. atroviridis</italic> 50&#x02009;mg/kg</th><th align="center" rowspan="1" colspan="1">
<italic>B. atroviridis</italic> 100&#x02009;mg/kg</th><th align="center" rowspan="1" colspan="1">
<italic>B. atroviridis</italic> 200&#x02009;mg/kg</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RBC (106&#x02009;<italic>&#x003bc;</italic>L)</td><td align="center" rowspan="1" colspan="1">7.22&#x02009;&#x000b1;&#x02009;0.52</td><td align="center" rowspan="1" colspan="1">4.92&#x02009;&#x000b1;&#x02009;0.556##</td><td align="center" rowspan="1" colspan="1">8.36&#x02009;&#x000b1;&#x02009;0.197</td><td align="center" rowspan="1" colspan="1">8.67&#x02009;&#x000b1;&#x02009;0.182<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">7.82&#x02009;&#x000b1;&#x02009;0.475<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">&#x02003;&#x02009;8.78&#x02009;&#x000b1;&#x02009;0.226<italic>&#x02217;&#x02217;&#x02217;</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">HGB (g/dL)</td><td align="center" rowspan="1" colspan="1">14.10&#x02009;&#x000b1;&#x02009;0.40</td><td align="center" rowspan="1" colspan="1">12.70&#x02009;&#x000b1;&#x02009;0.636</td><td align="center" rowspan="1" colspan="1">14.10&#x02009;&#x000b1;&#x02009;0.294</td><td align="center" rowspan="1" colspan="1">15.10&#x02009;&#x000b1;&#x02009;0.799<italic>&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">13.80&#x02009;&#x000b1;&#x02009;0.543</td><td align="center" rowspan="1" colspan="1">&#x02003;&#x02003;14.90&#x02009;&#x000b1;&#x02009;0.458</td></tr><tr><td align="left" rowspan="1" colspan="1">HCT (%)</td><td align="center" rowspan="1" colspan="1">47.00&#x02009;&#x000b1;&#x02009;0.40</td><td align="center" rowspan="1" colspan="1">40.50&#x02009;&#x000b1;&#x02009;1.31##</td><td align="center" rowspan="1" colspan="1">48.40&#x02009;&#x000b1;&#x02009;0.87<italic>&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">48.90&#x02009;&#x000b1;&#x02009;1.60<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">48.40&#x02009;&#x000b1;&#x02009;1.23<italic>&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">&#x02003;&#x02003;47.90&#x02009;&#x000b1;&#x02009;1.29<italic>&#x02217;&#x02217;</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">MCV (fL)</td><td align="center" rowspan="1" colspan="1">71.40&#x02009;&#x000b1;&#x02009;5.78</td><td align="center" rowspan="1" colspan="1">56.50&#x02009;&#x000b1;&#x02009;1.56#</td><td align="center" rowspan="1" colspan="1">58.00&#x02009;&#x000b1;&#x02009;0.45</td><td align="center" rowspan="1" colspan="1">57.00&#x02009;&#x000b1;&#x02009;0.87</td><td align="center" rowspan="1" colspan="1">55.70&#x02009;&#x000b1;&#x02009;1.70</td><td align="center" rowspan="1" colspan="1">&#x02003;54.60&#x02009;&#x000b1;&#x02009;0.59</td></tr><tr><td align="left" rowspan="1" colspan="1">MCH (pg)</td><td align="center" rowspan="1" colspan="1">26.40&#x02009;&#x000b1;&#x02009;4.37</td><td align="center" rowspan="1" colspan="1">16.30&#x02009;&#x000b1;&#x02009;0.17##</td><td align="center" rowspan="1" colspan="1">17.00&#x02009;&#x000b1;&#x02009;0.20</td><td align="center" rowspan="1" colspan="1">17.40&#x02009;&#x000b1;&#x02009;0.69</td><td align="center" rowspan="1" colspan="1">16.80&#x02009;&#x000b1;&#x02009;0.40</td><td align="center" rowspan="1" colspan="1">&#x02003;17.00&#x02009;&#x000b1;&#x02009;0.22</td></tr><tr><td align="left" rowspan="1" colspan="1">MCHC (g/dL)</td><td align="center" rowspan="1" colspan="1">36.70&#x02009;&#x000b1;&#x02009;3.48</td><td align="center" rowspan="1" colspan="1">29.20&#x02009;&#x000b1;&#x02009;0.32#</td><td align="center" rowspan="1" colspan="1">29.30&#x02009;&#x000b1;&#x02009;0.24</td><td align="center" rowspan="1" colspan="1">30.70&#x02009;&#x000b1;&#x02009;0.65</td><td align="center" rowspan="1" colspan="1">30.10&#x02009;&#x000b1;&#x02009;0.23</td><td align="center" rowspan="1" colspan="1">&#x02003;31.20&#x02009;&#x000b1;&#x02009;0.25</td></tr><tr><td align="left" rowspan="1" colspan="1">WBC (103&#x02009;<italic>&#x003bc;</italic>L)</td><td align="center" rowspan="1" colspan="1">3.88&#x02009;&#x000b1;&#x02009;0.54</td><td align="center" rowspan="1" colspan="1">6.04&#x02009;&#x000b1;&#x02009;0.11##</td><td align="center" rowspan="1" colspan="1">7.85&#x02009;&#x000b1;&#x02009;0.35</td><td align="center" rowspan="1" colspan="1">4.50&#x02009;&#x000b1;&#x02009;0.26</td><td align="center" rowspan="1" colspan="1">3.84&#x02009;&#x000b1;&#x02009;0.20<italic>&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">&#x02003;4.60&#x02009;&#x000b1;&#x02009;0.40</td></tr><tr><td align="left" rowspan="1" colspan="1">LYMP (%)</td><td align="center" rowspan="1" colspan="1">68.10&#x02009;&#x000b1;&#x02009;2.88</td><td align="center" rowspan="1" colspan="1">51.10&#x02009;&#x000b1;&#x02009;2.05##</td><td align="center" rowspan="1" colspan="1">77.90&#x02009;&#x000b1;&#x02009;2.35<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">74.10&#x02009;&#x000b1;&#x02009;3.06<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">77.30&#x02009;&#x000b1;&#x02009;2.02<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">&#x02003;&#x02003;68.40&#x02009;&#x000b1;&#x02009;3.61<italic>&#x02217;&#x02217;</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">PLT (103&#x02009;<italic>&#x003bc;</italic>L)</td><td align="center" rowspan="1" colspan="1">870.00&#x02009;&#x000b1;&#x02009;8.41</td><td align="center" rowspan="1" colspan="1">389.00&#x02009;&#x000b1;&#x02009;60.60###</td><td align="center" rowspan="1" colspan="1">653.00&#x02009;&#x000b1;&#x02009;16.10<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">721.00&#x02009;&#x000b1;&#x02009;41.8<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">716.00&#x02009;&#x000b1;&#x02009;13.4<italic>&#x02217;&#x02217;&#x02217;</italic></td><td align="center" rowspan="1" colspan="1">&#x02003;&#x02009;617.00&#x02009;&#x000b1;&#x02009;36.70<italic>&#x02217;&#x02217;</italic></td></tr></tbody></table><table-wrap-foot><fn><p>Values represent mean&#x02009;&#x000b1;&#x02009;SEM (<italic>n</italic>&#x02009;=&#x02009;5). #<italic>P</italic> &#x0003c; 0.05, ##<italic>P</italic> &#x0003c; 0.01, and ###<italic>P</italic> &#x0003c; 0.001: significant difference compared to normal control. <italic>&#x02217;P</italic> &#x0003c; 0.05; <italic>&#x02217;&#x02217;P</italic> &#x0003c; 0.01; and <italic>&#x02217;&#x02217;&#x02217;P</italic> &#x0003c; 0.001: significant difference related to diabetic control. Normal control&#x02009;=&#x02009;healthy animals treated with distilled water (10&#x02009;mL/kg). Diabetic control&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with distilled water (10&#x02009;mL/kg). Metformin 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with metformin at the dose of 200&#x02009;mg/kg. <italic>B. atroviridis</italic> 50&#x02009;mg/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg&#x02009;=&#x02009;nicotinamide-/streptozotocin-induced diabetic rats treated with <italic>B. atroviridis</italic> extract at the doses of 50&#x02009;m/kg, 100&#x02009;mg/kg, and 200&#x02009;mg/kg, respectively. RBC&#x02009;=&#x02009;red blood cell; HGB&#x02009;=&#x02009;haemoglobin; HCT&#x02009;=&#x02009;hematocrit; PLT&#x02009;=&#x02009;platelets; MCV&#x02009;=&#x02009;mean corpuscular volume; MCH&#x02009;=&#x02009;mean corpuscular haemoglobin; MCHC&#x02009;=&#x02009;mean corpuscular haemoglobin concentration; WBC&#x02009;=&#x02009;white blood cells; LYMP&#x02009;=&#x02009;lymphocytes; PLT&#x02009;=&#x02009;platelets.</p></fn></table-wrap-foot></table-wrap></floats-group></article>